Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that healthcare professionals should report adverse drug reactions to improve medication safety and patient care.

Ondansetron can cause serious allergic reactions, so use it carefully.

ERULUS controls root hair growth by regulating cell wall composition and pectin activity.

FERONIA is crucial for plant growth, pollen tube reception, and sugar signaling.

Zinc supplements and diet changes can effectively treat zinc deficiency and prevent complications.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Cosmerna ARI effectively reduces hair loss and increases hair density in Europeans with androgenetic alopecia.

A heterozygous mutation in HTRA1 can cause severe CARASIL symptoms.

Taking 5-alpha reductase inhibitors might be linked to breast cancer in men.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

The compounds tested could potentially treat hair loss and alopecia.

The P133R mutation in AKR1D1 enzyme causes harmful bile acid buildup, explaining related health issues.

A 69-year-old man with sinus infection and fainting spells was diagnosed with a rare kidney disease, treated with steroids and a specific drug, which improved his condition.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

The gel improves hair regrowth and reduces irritation in alopecia areata treatment.

A family got a fungal infection from a boy who had contact with rabbits, but they all recovered with treatment.

Referral rates for anaphylaxis patients improved significantly after implementing guidelines.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

EDA2R gene linked to hair loss.

Understanding how androgens and their receptors work can lead to improved treatments for skin diseases.

Starting 5-alpha reductase inhibitors does not significantly increase the risk of rhabdomyolysis in older men, but is linked to a higher risk of muscle conditions.

Men taking 5-alpha reductase inhibitors for prostate issues may be less likely to experience severe COVID-19, but it doesn't prevent ICU admission or death.

A 29-year-old woman with symptoms of both lupus and rheumatoid arthritis improved with specific medications.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

New compounds were made that are promising for prostate cancer therapy.

5α-reductase inhibitors do not increase anaemia risk compared to α-blockers in men with BPH.